Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-130378

Director sold 4,891 shares at an average $41.08 ($200,947)

  • Director gave up 1,695 shares (to pay taxes)
  • Director acquired 6,586 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PATOU GARY · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-22 Exercise or conversion : show line 1 in the form +3,500 $7.38 $25,830 27,073 D
2024-11-22 Shares withheld for taxes : show line 2 in the form −649 $39.80 $25,830 26,424 D
2024-11-22 Sale : show line 3 in the form −2,851 $41.11 $117,205 23,573 D
2024-11-22 Exercise or conversion : show line 4 in the form +3,086 $13.48 $41,599 26,659 D
2024-11-22 Shares withheld for taxes : show line 5 in the form −1,046 $39.80 $41,631 25,613 D
2024-11-22 Sale : show line 6 in the form −2,040 $41.05 $83,742 23,573 D
Open-market sales · 4,891 sh · avg $41.08 · $200,947

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-11-22 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −3,500 0 D
2024-11-22 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −3,086 0 D
Loading xslF345X05/ownership.xml…